Business Context and Reporting Period
Prestige Brands Holdings, Inc. (now Prestige Consumer Healthcare Inc.) filed this Form 8-K on September 14, 2010, to disclose the entry into a definitive stock purchase agreement. The Company agreed to acquire all outstanding shares of Blacksmith Brands Holdings, Inc. ("Holdco"), which owns the Pediacare, Luden's, Efferdent, Effergrip, and NasalCrom brands.
Key Financial Metrics
- Purchase Price: $190.0 million in cash, subject to a customary working capital adjustment.
- Escrow Funds: $7.5 million for indemnification and $1.2 million for working capital adjustments.
- Termination Fee: $7.5 million payable by the Company if it fails to close despite satisfying all other conditions.
- Financial Performance: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company or the target.
Material Changes and Transaction Details
The primary material change is the proposed acquisition of Blacksmith Brands Holdings, Inc. The transaction is expected to close during the fourth quarter of 2010, subject to customary conditions including regulatory clearance under the Hart-Scott-Rodino Antitrust Improvements Act. The agreement has a termination date of December 31, 2010, extendable by up to 60 days. The deal is not subject to a financing condition.
Outlook, Risks, and Management Commentary
- Outlook: Management expects to close the transaction in Q4 2010 and began investor presentations on September 20, 2010.
- Risks: The transaction is contingent on regulatory approval. If the Company cannot close due to reasons other than financing, it faces a $7.5 million termination fee.
- Contingencies: The purchase price is adjustable based on working capital. Indemnification provisions generally survive for one year post-closing.
- Unusual Items: None reported in this filing.
Investor Verification Checklist
- Verify the final closing date and whether the transaction was completed in Q4 2010 as expected.
- Confirm receipt of regulatory clearance under the Hart-Scott-Rodino Act.
- Review the final purchase price after working capital adjustments.
- Assess the integration progress of the acquired brands (Pediacare, Luden's, Efferdent, Effergrip, NasalCrom) into the Company's portfolio.
- Check subsequent filings for any updates on the $7.5 million termination fee risk or escrow fund utilization.